News

Monday August 17, 2020

17 Aug 2020 – Destiny Pharma welcomes NBIC #BiofilmAware campaign, launched today

Destiny Pharma, as an NBIC industrial partner, is currently working on three NBIC funded research projects in collaboration with expert teams at the Universities of Cardiff, Sheffield and Southampton. The […]

Tuesday August 11, 2020

11 Aug 2020 – Positive interim safety review of Phase 2b clinical trial of lead as...

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Positive interim safety review of Phase 2b clinical trial of lead asset XF-73 in the prevention of post-surgical bacterial infections Brighton, United […]

Friday August 7, 2020

07 Aug 2020 – Could drug-resistant bacteria cause the next pandemic? – Forbes

A new article on the Forbes website poses the question, ‘Could drug-resistant bacteria cause the next pandemic?’ and highlights the need to fund and incentivise the discovery and development of […]

Wednesday August 5, 2020

05 Aug 2020 – Neil Clark, CEO, interviewed by Equity Development

Neil Clark, CEO of Destiny Pharma has been interviewed by Andy Edmond from Equity Development, the UK’s leading independent investment research company. Please follow the link below to watch the […]